Therapy of Spondyloarthritides-Reference-Cited by-同舟云学术

Therapy of Spondyloarthritides

Published:2009 Issue: Volume: Page:133-147
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Braun Jürgen

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-0298-6_10.pdf

Reference92 articles.

1. Braun J, Sieper J. Ankylosing spondylitis. The Lancet 2007; 369:1379–1390.

2. Zochling J, van der Heijde D, Burgos-Vargas R et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum Dis 2006; 65(4):442–52.

3. Braun J, Davis J, Dougados M et al. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65(3):316–20.

4. Zochling J, Braun J. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 2007; 21(4):699–712.

5. van der Heijde D, Bellamy N, Calin A et al. Assessments in ankylosing spondylitis working group. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997; 24:2225–29.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional limitations due to foot involvement in spondyloarthritis;Journal of Physical Therapy Science;2016

2. Association of β-defensin gene copy number variations with ankylosing spondylitis in Chinese population: A case–control study;Modern Rheumatology;2015-08-19

3. Tumor Necrosis Factor–α Promoter −308/238 Polymorphism Association with Less Severe Disease in Ankylosing Spondylitis is Unrelated to Serum TNF-α and Does Not Predict TNF Inhibitor Response;The Journal of Rheumatology;2014-07-15

4. The Microbiome and Psoriatic Arthritis;Current Rheumatology Reports;2014-01-29

5. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema;Annals of Allergy, Asthma & Immunology;2013-04